Healthcare -
Biotechnology - NASDAQ - US
$ 4.585
-1.98 %
$ 282 M
Market Cap
-4.55
P/E
GLUE - STOCK-BASED COMPENSATION
Stock-based Compensation GLUE - Monte Rosa Therapeutics, Inc.
18.1 M
LAST VALUE
24.66%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR